Clinical Trial

MyoVasc Study on the Development and Progression of Heart Failure

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The MyoVasc - Study is an observational, prospective cohort study. The study is investigating the development and progression of the heart failure syndrome, phenotypes of the heterogeneous syndrome, and the interactions of phenotypes with the vasculature regarding their impact for the course of heart failure.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2019-08-20; most recent amendment 2024-08-20.
Trial Details
NCT Number NCT04064450
Lead Sponsor Johannes Gutenberg University Mainz
Conditions Heart Failure
Enrollment 3,289 participants
Start Date 2013-01
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2024-08-22